|
HUWE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71404999999014E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.32700000000797E-05 |
| Normal-vs-Stage2 |
5.589600E-02 |
| Normal-vs-Stage3 |
2.81729999995761E-06 |
| Normal-vs-Stage4 |
2.03540000000002E-05 |
| Stage1-vs-Stage2 |
1.903190E-01 |
| Stage1-vs-Stage3 |
2.274600E-01 |
| Stage1-vs-Stage4 |
2.231400E-01 |
| Stage2-vs-Stage3 |
4.303600E-02 |
| Stage2-vs-Stage4 |
5.825500E-02 |
| Stage3-vs-Stage4 |
9.040200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58370999999713E-05 |
| Normal-vs-AfricanAmerican |
9.054100E-02 |
| Normal-vs-Asian |
3.577000E-03 |
| Caucasian-vs-AfricanAmerican |
2.010200E-01 |
| Caucasian-vs-Asian |
6.627000E-01 |
| AfricanAmerican-vs-Asian |
4.174000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01930000000017E-05 |
| Normal-vs-Female |
4.22290000000602E-05 |
| Male-vs-Female |
2.909800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.826800E-04 |
| Normal-vs-Age(41-60Yrs) |
9.76799999999889E-05 |
| Normal-vs-Age(61-80Yrs) |
1.73545999999636E-05 |
| Normal-vs-Age(81-100Yrs) |
1.796240E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.603800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.017200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.503400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.579800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.148600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.432000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.212150E-01 |
| Classical-VS-Follicular |
9.964800E-03 |
| Classical-VS-Other |
1.439390E-01 |
| Classical-VS-Normal |
6.047000E-04 |
| Tall-VS-Follicular |
8.640400E-01 |
| Tall-VS-Other |
4.777600E-01 |
| Tall-VS-Normal |
2.390500E-04 |
| Follicular-VS-Other |
6.075200E-01 |
| Follicular-VS-Normal |
1.69106999999835E-05 |
| Other-VS-Normal |
7.457500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.191810E-04 |
| Normal-vs-N1 |
1.09449999996514E-06 |
| N0-vs-N1 |
4.453900E-02 |
|
|
